#SARS-CoV-2

COVID is associated with serious illness in mothers and newborns. Findings reinforce need for targeted interventions, including vaccination.

Before they get COVID, people over 65 should have a plan for accessing antiviral treatment.

Berks County, Pennsylvania, is the first community to join a partnership with local public health departments.

Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.

The antiviral treatment reduced the risk of hospitalization or death from SARS-CoV-2 Omicron variants in older adults by 44%.

NIH-supported study finds no serious complications following rare immune condition.

Investigational drug works differently than antibody drugs which are losing effectiveness against the SARS-CoV-2 virus.

Early findings of widespread, long-lasting virus helps inform long COVID research.

A single vaccine dose delivered to nose aims to protect children and adults against COVID.

Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.

Fauci, who has directed the National Institute of Allergy and Infectious Diseases since 1984, will step down in December.

COVID-19 test results provide valuable data that public health departments can use to assess needs and modify responses.

COVID can also affect the gut lining, which may allow pathogenic bacteria to enter the bloodstream and cause secondary infections.

These three respiratory illnesses—and others—share many of the same symptoms.

Researchers found that today’s COVID rapid antigen tests can identify all current variants of concern and interest.

Study finds that HIV-positive people are four times more likely to experience long-term COVID symptoms.